Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy

Clinical trial NCT04711330 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04711330
Sponsor: Leiden University Medical Center
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Stage III Immunotherapy

Start date: 2022-09-01
Primary completion: 2025-10-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.